Glenmark Pharmaceuticals Logo

Glenmark Pharmaceuticals

🇮🇳
532296
INE935A01035

Glenmark Pharmaceuticals is a leading research-driven pharmaceutical company from India, engaged in the development, manufacturing, and marketing of high-quality generics, innovative medicines, and APIs globally. The company focuses on therapeutic areas including respiratory diseases, dermatology, and oncology, aiming to provide enhanced healthcare solutions to patients worldwide.

Next Quarterly Earnings

Friday, November 6, 2026
CW 45
Pre-Market
In 71 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 9, 2026

Stock Price

Frequently asked questions

When will Glenmark Pharmaceuticals report its next quarterly earnings?

Glenmark Pharmaceuticals is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Glenmark Pharmaceuticals last report quarterly earnings?

Glenmark Pharmaceuticals last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 17.11 INR.

How do I add the Glenmark Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q2 2026
Beat
Estimate:₹17.10
Actual:₹17.11
Difference:+₹0.01
Q1 2026
Estimate:
Actual:₹10.68
Q4 2025
Missed
Estimate:₹18.70
Actual:₹14.28
Difference:-₹4.42
Q3 2025
Estimate:
Actual:

Company Information

Name
Glenmark Pharmaceuticals
Ticker Symbol
532296
ISIN
INE935A01035
Country
🇮🇳
India
Sector